Tusup, M.; Läuchli, S.; Jarzebska, N.T.; French, L.E.; Chang, Y.-T.; Vonow-Eisenring, M.; Su, A.; Kündig, T.M.; Guenova, E.; Pascolo, S.
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma. Pharmaceutics 2021, 13, 1040.
https://doi.org/10.3390/pharmaceutics13071040
AMA Style
Tusup M, Läuchli S, Jarzebska NT, French LE, Chang Y-T, Vonow-Eisenring M, Su A, Kündig TM, Guenova E, Pascolo S.
mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma. Pharmaceutics. 2021; 13(7):1040.
https://doi.org/10.3390/pharmaceutics13071040
Chicago/Turabian Style
Tusup, Marina, Severin Läuchli, Natalia Teresa Jarzebska, Lars E. French, Yun-Tsan Chang, Maya Vonow-Eisenring, Andreas Su, Thomas M. Kündig, Emmanuella Guenova, and Steve Pascolo.
2021. "mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma" Pharmaceutics 13, no. 7: 1040.
https://doi.org/10.3390/pharmaceutics13071040
APA Style
Tusup, M., Läuchli, S., Jarzebska, N. T., French, L. E., Chang, Y. -T., Vonow-Eisenring, M., Su, A., Kündig, T. M., Guenova, E., & Pascolo, S.
(2021). mRNA-Based Anti-TCR CDR3 Tumour Vaccine for T-Cell Lymphoma. Pharmaceutics, 13(7), 1040.
https://doi.org/10.3390/pharmaceutics13071040
